Chai is an applied research lab working on AI to unlock biology. Our models design new molecules for new medicines. Scientists across industry are adopting our software platform to develop drugs with engineering precision. Our vision is to build a design suite for biology, with applications across life sciences, agriculture, materials science and beyond.
Our founders have been at the forefront of this field since its inception. We raised $230m from Thrive, General Catalyst, OpenAI, Dimension and other tier-one investors. We partner with global life sciences companies like Eli Lilly on deals that are transforming the industry landscape.
We are known for talent density, rigorous research and pace of execution.
About the roleWe are building out our partnerships founding team and looking to make a few key hires to anchor the effort. You will help set the terms and drive deal execution with the world's leading life sciences companies, establishing relationships that will shape our future.
These are complex transactions with sophisticated partners. You'll need to lean into the many details that make these partnerships work, while creating urgency and alignment around a common vision.
This is a critical role at a pivotal time for the business: Deal volume and demand are accelerating fast. It will be a lot of fun, a lot of work, and extraordinarily rewarding.
About youWe index on outlier performance and relentless execution. You sweat the small stuff, you think big, you always take ownership, and you strive for win-win outcomes. We can count on you.
We value biopharma domain experience and deal-making savvy, and we are also more than willing to make a bet on rising talent. Low-ego, high-EQ, motivated and mission-driven is what we're looking for.
We offerThe opportunity to work at the frontier of AI, with world-class people, on a mission that matters. We protect & promote a culture of high velocity and ownership. We offer highly competitive compensation.
What We Do
Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.








